| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6054650 | Oral Oncology | 2016 | 6 Pages |
Abstract
Treatment with IPI-926 and cetuximab yielded expected toxicities with signs of anti-tumor activity. Serial tumor biopsies were feasible and revealed proof-of-concept biomarkers.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Daniel W. Bowles, Stephen B. Keysar, Justin R. Eagles, Guoliang Wang, Magdalena J. Glogowska, Jessica D. McDermott, Phuong N. Le, Dexiang Gao, Charles E. Ray, Paul J. Rochon, Dennis R. Roop, Aik-Choon Tan, Hilary S. Serracino, Antonio Jimeno,